RBCC Nears Deal With Leading Genetic Testing Lab

  RBCC Nears Deal With Leading Genetic Testing Lab

Business Wire

NOKOMIS, Fla. -- April 15, 2013

Rainbow BioSciences, the biotech division of Rainbow Coral Corp. (OTCBB:
RBCC), today announced that it is wrapping up negotiations toward a definitive
agreement with a leading, Texas-based genetic testing laboratory.

The genetic testing sector is one of the fastest-growing segments of the
global biotech industry, with some market experts expecting it to reach $2.2
billion by 2017. RBCC is nearing a deal with a company that specializes in the
cutting-edge science of pharmacogenomics, a field of study resulting from the
Human Genome Project that seeks to help doctors assess genetic variations in
patients in order to create more effective, optimized drug treatment plans.

Pharmacogenomics could be the key to truly personalized medicine, which RBCC
views as the future of healthcare.

For more information on Rainbow BioSciences’ personalized medicine
initiatives, please visitwww.rainbowbiosciences.com/investors.html.

Rainbow BioSciences will develop new medical and research technology
innovations to compete alongside companies such as Bristol Myers Squibb Co.
(NYSE:BMY),Biogen Idec Inc. (NASDAQ:BIIB), Abbott Laboratories (NYSE:ABT)
and Amgen Inc. (NASDAQ:AMGN).

About Rainbow BioSciences

Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp.
(OTCBB:RBCC). The Company continually seeks out new partnerships with
biotechnology developers to deliver profitable new medical technologies and
innovations. For more information on our growth-oriented business initiatives,
please visitwww.RainbowBioSciences.com. For investment information and
performance data on the Company, please
visitwww.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including statements
that include the words "believes," "expects," "anticipate" or similar
expressions. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the Company to differ materially from those expressed or
implied by such forward-looking statements. In addition, description of
anyone's past success, either financial or strategic, is no guarantee of
future success. This news release speaks as of the date first set forth above
and the Company assumes no responsibility to update the information included
herein for events occurring after the date hereof.

Contact:

Rainbow Coral Corp.
Patrick Brown, 850-269-7230
President and CEO
info@rainbowcoral.com
 
Press spacebar to pause and continue. Press esc to stop.